Abstract
Aims: The ABSORB bioresorbable vascular scaffold (BVS) is an everolimus-eluting scaffold that has limited long-term safety data. This dual-centre, prospective registry aimed to evaluate the long-term, out-of-hospital outcomes among patients who underwent percutaneous coronary intervention (PCI) with BVS.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
